Publications

Antimicrobial Activity of Daptomycin Tested Against Multidrug-Resistant Gram-Positive Strains Collected in European Hospitals (2003-2007), Lead author: Sader HS, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Antimicrobial Activity of Daptomycin and Comparator Agents Tested Against Gram-positive Organisms from Hong Kong, Indonesia, Philippines, Singapore and Thailand, Lead author: Turnidge JD, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Daptomycin Activity Tested Against Gram-positive Bacteria Isolated from Medical Centers Located in China (2006), Lead author: Chen, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Multicenter Evaluation of Tigecycline Activity in India: Report from the SENTRY Antimicrobial Surveillance Program (2006), Lead author: Jones RN, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Multicenter Evaluation of Tigecycline: An in Vitro Update Against Clinical Pathogens from Japan (2006-2007), Lead author: Kohno, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Dalbavancin Tested Against Staphylococcus spp. and Streptococcus spp. Isolates collected from Five European Counties: Comprehensive DECIDE Program Results (2007), Lead author: Biedenbach DJ, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Activity of Tigecycline against Clinical Pathogens Collected in Indonesia (2006), Lead author: Turnidge JD, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Tigecycline Activity against Isolates from Medical Centers Located in China, Hong Kong and Taiwan (2006): A SENTRY Antimicrobial Surveillance Program Report, Lead author: Chen, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

Antimicrobial Activity of Tigecycline Tested against Contemporary Bacterial Isolates Collected in Australia (2006), Lead author: Bell JM, presented at 13th annual International Congress on Infectious Diseases (ICID), June 19 – 22, 2008, Kuala Lumpur, Malaysia

A Multi-Site Study of a Broth Cefoxitin Screen Test Using TREK Sensititre® 18-24 Hour Dried Susceptibility Plates for Predicting the Presence of mecA-Mediated Resistance in Staphylococcus aureus, Lead author: Knapp C, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Detection of cfr rRNA Methyltransferases among Staphylococcus aureus and Coagulase-Negative Staphylococci Recovered from Human Infections, Lead author: Castanheira M, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Worldwide Generic Piperacillin/Tazobactam (P/T) Comparison to Branded Product: A Contemporary Assessment of 31 Intravenous Formulations, Lead author: Moet G, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Multi-Center Surveillance Results (3,617 strains) Comparing the Gram-Positive Activity of Dalbavancin in the United States and Europe During 2005-2007, Lead author: Biedenbach DJ, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Comparative Activity of Meropenem and Other Broad-Spectrum Antimicrobials: Resistance Surveillance Testing Results from the USA MYSTIC Program (2007), Lead author: Rhomberg PR, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Linezolid Experience and Accurate Determination of Resistance (LEADER) Program 2007: Assessing Oxazolidinone and Inducible Clindamycin Resistance, Lead author: Ross JE, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Antimicrobial Activity of Doripenem Against Leading Bacterial Pathogens: Results from a Latin American Surveillance Study (2003-2006), Lead author: Gales AC, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Regression Analysis of MIC Versus Disk Diffusion Zone Diameters for Three Carbapenems Tested against Enterobacteriaceae Isolates Harboring Serine Carbapenemases with Matched Control Strains, Lead author: Fritsche TR, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Proposed Susceptibility Testing Criteria for H. influenzae Tested Against Piperacillin/Tazobactam: Report Using Results from the SENTRY Program and Japan Surveillance Isolates, Lead author: Jones RN, presented at 108th annual American Society for Microbiology General Meeting (ASM), June 1 – 5, 2008, Boston, MA

Critical evaluations of generic piperacillin/tazobactam compared to the branded product: a worldwide sampling of 26 intravenous formulations, Lead author: Moet G, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Increased antimicrobial susceptibility profiles among polymyxin-B-resistant Acinetobacter baumannii clinical isolates, Lead author: Mendes RE, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Analyses supporting phase 2 clinical trial dose selection for zabofloxacin in community-acquired pneumonia, Lead author: Ambrose PG, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Characterisation of baseline methicillin-resistant Staphylococcus aureus isolates from a phase IV clinical trial of complicated skin and soft tissue infections, Lead author: Mendes RE, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Occurrence of carbapenemase-producing Enterobacteriaceae clinical isolates in the Asia-Pacific nations, Lead author: Mendes RE, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Acquired carbapenemase-encoding genes among Gram-negative isolates in USA medical centres: report from the MYSTIC Program (2007), Lead author: Mendes RE, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Daptomycin activity and spectrum when tested against Gram-positive species responsible for bloodstream infections in European medical centres, Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Activity of tigecycline tested against vancomycin-resistant enterococci, including clonal complex-17 E. faecium strains, isolated in Europe, Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

A Global Evaluation of Voriconazole Activity Against Recent Clinical Isolates of Candida spp., Lead author: Diekema DJ, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Antimicrobial activity of telavancin against Enterococcus faecalis, E. faecium and E. avium: results from a European surveillance program (2007), Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Activity of telavancin tested against viridans group and beta-haemolytic streptococci, and multidrug-resistant Streptococcus pneumoniae, Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Antimicrobial activity of telavancin and comparator agents tested against recently isolated (2007) European Staphylococcus aureus and coagulase-negative staphylococci, Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Dalbavancin (DECIDE) tested against indicated Gram-positive species in European medical centres: results from France, Lead author: Leclercq, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Comparative activity of dalbavancin tested against indicated Gram-positive species in Europe: results from two Spanish medical centres (DECIDE Program), Lead author: Canton R, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Definition of wildtype MIC distributions for targeted species for determination of optimal dosing for zabofloxacin, a novel fluoronaphthyridone, Lead author: Jones RN, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Antimicrobial activity of ceftobiprole tested against leading European bacterial pathogens: results from an international surveillance programme (2005-2006), Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Enhanced activity of daptomycin and vancomycin combined with imipenem or oxacillin against community-acquired MRSA isolates, Lead author: Jones RN, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Rapid emergence and dissemination of bla_CTX-M among Enterobacteriaceae in USA medical centres: report from the MYSTIC Program (2007), Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Resistance surveillance of bacterial pathogens from North American patients hospitalised with pneumonia: a 10-year report from the SENTRY Program (1997-2006), Lead author: Fritsche TR, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Escalating resistance among non-fermentative Gram-negative bacilli: Report from the North American SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Trends in prevalence and antimicrobial susceptibilities among skin and skin structure infection pathogens in North America: Report from the SENTRY Program (1997-2005), Lead author: Moet G, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Acinetobacter spp. infections: the Latin American scenario in the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Gales AC, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Potency and spectrum of tigecycline tested against bacterial pathogens producing skin and skin structure infections in European medical centres, including community-acquired methicillin-resistant S. aureus, Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

In vitro activity of tigecycline tested against pneumonia pathogens from patients hospitalised in European medical centres, including multidrug-resistant Acinetobacter spp., Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Tigecycline activity tested against bacterial isolates causing bloodstream infections in European medical centres, Lead author: Sader HS, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Analysis of resistance and vancomycin &quotreverse creep&quot in Latin American Staphylococcus aureus: ten-year report of the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Picao, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Frequency and antimicrobial susceptibility profile of vancomycin-resistant enterococci from Latin America: a report from the SENTRY Antimicrobial Surveillance Program (1997-2006), Lead author: Gales AC, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Prevalence of vancomycin-resistant Enterococcus spp. and associated resistance patterns among isolates collected over a decade of SENTRY Program surveillance in North America, Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Genetic characterisation of the new blaVIM-18 and comparative antimicrobial susceptibility profile of VIM-18 with highest homologous VIM-variant, VIM-2: report from the SENTRY Antimicrobial Surveillance Program, Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

High carbapenem resistance among Pseudomonas aeruginosa from India: a national epidemic of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, -11 and new VIM-18), Lead author: Castanheira M, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

bla_VIM-2-carrying integron among Enterobacteriaceae isolates in Mexico: report from the SENTRY Antimicrobial Surveillance Program, Lead author: Deshpande LM, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain

Wide variation in rates of ESBL production among Escherichia coli causing bacteraemia in the Asia-Pacific region: A SENTRY Program Report, Lead author: Bell JM, presented at 18th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 19 – 22, 2008, Barcelona, Spain